Subscription banner for an ophthalmic newsletter
OMNI Surgical System Greatly Reduces Medication Usage in Glaucoma Patients

In glaucoma patients, OMNI Surgical System technology in combination with cataract showed greater re...

read more
OMNI Surgical System Greatly Reduces Medication Usage in Glaucoma Patients
May 16, 2023
Glaukos' iDose TR for Glaucoma Hits the Market

Glaukos Corporation's iDose TR, using Celanese's VitalDose EVA (Ethylene Vinyl Acetate), to provide ...

read more
Glaukos' iDose TR for Glaucoma Hits the Market
March 04, 2024
Cyclodialysis Procedure with Scleral Reinforcement Effectively Lowers IOP in Open-Angle Glaucoma

A recent study published in Clinical Ophthalmology demonstrated that a bio-interventional cyclodialy...

read more
Cyclodialysis Procedure with Scleral Reinforcement Effectively Lowers IOP in Open-Angle Glaucoma
December 31, 2024
CMS J-Code for Glaukos’ iDose TR Becomes Active

Glaukos Corporation has confirmed the activation of the CMS Healthcare Common Procedure Coding Syste...

read more
CMS J-Code for Glaukos’ iDose TR Becomes Active
July 03, 2024
Prevent Blindness Offers Free Glaucoma Resources for Patients, Care Partners, and Professionals

In recognition of National Glaucoma Awareness Month in January, the non-profit organization Prevent ...

read more
Prevent Blindness Offers Free Glaucoma Resources for Patients, Care Partners, and Professionals
January 02, 2025
NurExone Launches Study on Exopten Therapy for Glaucoma Treatment

NurExone Biologic has initiated a preclinical study to investigate the potential of its exosome-base...

read more
NurExone Launches Study on Exopten Therapy for Glaucoma Treatment
July 03, 2024
AI-Driven Discovery Uncovers Potential Treatment for Acute Glaucoma

Acute glaucoma, characterized by retinal ganglion cell (RGC) death due to acute ocular hypertension,...

read more
AI-Driven Discovery Uncovers Potential Treatment for Acute Glaucoma
January 03, 2025
The Crucial Role of Corneal Hysteresis in Glaucoma Risk Assessment

Corneal hysteresis is a measure of the cornea's ability to absorb and dissipate energy when subjecte...

read more
The Crucial Role of Corneal Hysteresis in Glaucoma Risk Assessment
November 28, 2023
Lumibird Medical Rebrands Its Japanese Subsidiary

Lumibird Medical has announced the rebranding of its Japanese subsidiary. Previously operating under...

read more
Lumibird Medical Rebrands Its Japanese Subsidiary
January 07, 2025
Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual Faces of Glaucoma Campaign

Bausch + Lomb and the Glaucoma Research Foundation (GRF) have partnered for the second annual Faces ...

read more
Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual Faces of Glaucoma Campaign
January 08, 2025
More